Name | AVN-322 free base |
---|
Description | A highly selective, potent, BBB penetrant and orally bioavailable 5-HT6R antagonist for the treatment of neurological disorders such as AD and schizophrenia; significantly restores both scopolamine- and MK-801-induced cognitive dysfunction and demonstrates antipsychotic potential. Alzheimer Disease Phase 2 Clinical |
---|---|
References | References 1. Ivachtchenko AV, et al. Curr Alzheimer Res. 2017;14(3):268-294. View Related Products by Target 5-HT Receptor Alzheimer Disease |
Molecular Formula | C17H19N5O2S |
---|---|
Molecular Weight | 357.432 |